Clinical trial
Earlier Diagnosis of Peripheral Neuropathy Using A Simple sCreening Tool (ACT)
NCT07163000 is registered in ClinicalTrials.gov with Weill Cornell Medical College in Qatar as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Earlier Diagnosis of Peripheral Neuropathy Using A Simple sCreening Tool (ACT)
- Lead sponsor
- Weill Cornell Medical College in Qatar
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- May 11, 2025
- Completion date
- December 30, 2026
- Enrollment
- 150 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes (dm), painful neuropathy, peripheral neuropathy